Skip to main content
. 2020 Mar 4;10:145. doi: 10.3389/fonc.2020.00145

Table 4.

Kaplan-Meier estimates of overall survival and cancer-specific survival of colorectal cancer patients (n = 1,002).

Variable Categories Cases Global survival Cancer-specific survival
Deaths 5 years p-value Deaths 5 years p-value
All cases 1,002 489 58.2 422 62.3
Gender Male 520 275 54.4 0.004 236 58.9 0.011
Female 482 214 62.3 186 65.8
Age at diagnose <50 290 134 62.0 0.066 133 62.4 0.368
(in years) ≥50 to <75 606 299 57.0 257 61.4
≥75 106 56 55.0 32 67.7
Brazilian region of origin South / Southeast 822 405 57.9 0.514 352 61.7 0.609
Midwest 87 37 65.3 32 69.8
North / Northeast 93 47 54.0 38 59.9
Primary tumor site Right colon 250 111 60.0 0.289 90 65.7 0.168
Left colon 466 221 58.9 195 62.2
Rectum 285 156 55.6 136 59.6
Clinical stage (AJCC) 0/I 125 29 86.4 <0.001 15 93.9 <0.001
II 376 126 72.5 97 78.2
III 332 175 54.4 156 57.8
IV 167 157 13.6 154 13.9
Histological type Adenocarcinoma 937 458 58.5 0.004 395 62.6 0.009
Mucinous 58 25 60.1 22 62.2
Others 7 6 14.3 5 17.1
Histological grade I/II 924 441 59.6 0.001 380 63.7 0.002
III/Undifferentiated 63 41 37.4 35 41.1
Lymphovascular No 621 227 69.7 <0.001 180 74.9 <0.001
invasion Yes 300 200 40.6 184 42.8
Perineural invasion No 731 301 64.9 <0.001 248 69.8 <0.001
Yes 123 89 35.4 85 36.0
Presence synchronous No 944 463 58.2 0.967 403 62.1 0.487
tumors Yes 58 26 58.6 19 65.3
Presence of recurrence No 698 245 67.8 <0.001 182 74.2 <0.001
Yes 304 244 36.5 240 36.9
Treatment period 2000–2009 184 142 49.5 <0.001 138 50.2 <0.001
2010–2014 818 347 60.3 284 65.3
Surgery No 40 38 7.5 <0.001 37 7.7 <0.001
Yes 961 450 60.4 385 64.6
Neoadjuvant chemotherapy No 18 14 38.9 0.002 10 46.7 0.034
Yes 159 80 59.1 71 62.7
Adjuvant chemotherapy No 543 313 49.4 <0.001 260 54.6 <0.001
Yes 442 169 69.1 157 71.0
Radiotherapy No 793 376 58.6 <0.001 322 62.8 <0.001
Yes, neoadjuvant 165 85 58.7 73 63.0
Yes, adjuvant 21 7 81.0 7 81.0
Yes, paliative 21 20 19.0 20 19.0
AFR Low 347 171 58.0 0.403 148 62.2 0.308
Intermediate 277 139 56.7 119 60.8
High 310 137 60.2 114 64.9
EUR Low 316 140 61.3 0.247 117 66.0 0.228
Intermediate 315 160 55.0 136 59.1
High 303 147 58.8 128 63.0
ASN Low 445 215 57.6 0.833 184 62.1 0.819
Intermediate 205 101 59.2 86 63.2
High 284 131 58.8 111 63.3
AME Low 404 190 58.9 0.859 167 63.0 0.949
Intermediate 231 109 58.7 95 61.6
High 299 148 57.2 119 63.2

Significant associations are indicated in bold.